RTTNews | Sep 7, 2021 06:12AM EDT

06:12 Tuesday, September 7, 2021 (RTTNews) - Natera Agrees With NRG Oncology To Use Signatera Personalized Molecular Residual Disease Test In NRG-GI008

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved